PHEN TV
Prostate Health Education Television

To Treat, Or Not To Treat Prostate Cancer
Dr. Philip Kantoff presents research data examining active surveillance (watchful waiting) as a treatment option. Dr. Clare Tempany-Afdhal looks at imaging technologies as a means of active surveillance. Moderated by Dr. Jacques Carter - 3rd Annual Summit, September 2007.

   

You Are Watching

Active Surveillance as an Option
Presentation by Philip Kantoff, MD, Chief Clinical Research Officer and Chief, Division of Solid Tumor Oncology, Dana-Farber Cancer Institute. Boston, MA

Previous Video   Next Video


Other Videos from this Program

Active Surveillance as an Option
Active Surveillance as an Option
Imaging as a Valuable Tool
Imaging as a Valuable Tool
Q&A
Q&A

PHEN,Inc. © 2018 All rights reserved